Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
about
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and managementAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesMolecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus).Current progress in the development of a prophylactic vaccine for HIV-1.Vaccine protection against feline immunodeficiency virus: setting the challenge.2008 American Association of Feline Practitioners' feline retrovirus management guidelines.Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccineDNA vaccines in veterinary use.Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.Advances in FIV vaccine technology.Feline immunodeficiency virus model for designing HIV/AIDS vaccines.Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.Differential CXCR4 expression and function in subpopulations of the feline lymphoma cell line 3201 susceptible to feline immunodeficiency virus.Duration of antibody response following vaccination against feline immunodeficiency virus.Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodiesFeline leukemia and feline immunodeficiency virus in Canada - A comment.The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?Feline immudeficiency virus subtypes B and A in cats from São Luis, Maranhão, Brazil.Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.Feline immunodeficiency virus subtypes in domestic cats in New Zealand.Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia.Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses
P2860
Q26829717-0D9A40FE-8E07-4873-865C-59527F0D154FQ27489000-23CFBAF1-F141-4765-ACBC-B985CF15FB14Q33653241-174F0006-A026-4C6C-BCD0-2A0A4D7D9A84Q34502108-6E85F2E6-F5AA-44CF-87CE-C8D351EC4ACEQ34575552-4F8CCF7C-5E33-4287-A8FF-365FB70B0FB9Q34775753-CBDD2886-D621-4D04-BFE7-6F8A8F7113B7Q35082956-739C13C5-0C5F-4BFA-B49C-3797A6C57B64Q35586830-3E4B3E93-AB06-4236-AD06-C671A3DF31E1Q36600380-3860C933-286E-4301-BF40-A33CEF208BAAQ36634847-52F835C2-864E-46BA-AF5A-AE9E6A8791ADQ37704546-5359C49B-C0D0-4A80-90B4-4B20409A811FQ38113162-8CF45050-5F92-4501-9FD7-35FC33B3656BQ39777823-72B7166C-2DDD-4B73-853C-FCB4104F29C5Q40492566-18031DDD-475A-4A3C-97C5-61BC2282A48CQ42257512-7134275D-C4B8-4B39-958E-19F59A438D1EQ43013440-462BA9A7-E97B-40F2-BE70-083947622AD8Q43378526-60C5F424-D552-4EA5-BDBB-4FECAAA18C90Q45324878-23EFA419-9473-4C00-8B19-C932FA0624A2Q45378493-AB51A0EF-2E03-48FE-82BA-7966B20916DBQ45398836-C2A4C6C7-C114-428C-8EEE-40C7D973C19BQ45417428-2D1A1788-4D32-49AC-8E6D-00086C03E64EQ54984932-CE896E5E-9E43-4FD4-BFE3-AD758B4EE371Q56977004-F285876B-F226-4B28-84A6-B9F7E2061DF2
P2860
Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@ast
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@en
Dual-subtype vaccine
@nl
type
label
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@ast
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@en
Dual-subtype vaccine
@nl
prefLabel
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@ast
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@en
Dual-subtype vaccine
@nl
P2093
P1476
Dual-subtype vaccine (Fel-O-Va ...... s subtype B FIV infected cats.
@en
P2093
Chengjin Huang
Hajime Kusuhara
Hiroyuki Koyama
Kayoko Sato
Kenji Motokawa
Mayuko Okumura
Rie Watanabe
Setsuo Arai
Tsutomu Hohdatsu
Tsuyoshi Gemma
P304
P356
10.1016/J.VETMIC.2005.02.014
P577
2005-07-01T00:00:00Z